Therapeutics: Interleukin-1 receptor-associated kinase 3 (IRAK3)

Patient sample, cell culture and mouse studies suggest inhibiting IRAK3 could help treat colorectal cancer (CRC). In patients, high tumor levels of IRAK3 correlated with disease progression and poor s...